Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Accident; Analysis and Prevention
|
December 14, 2002
Field relevance of a suite of rollover tests to real-world crashes and injuries
Chantal S Parenteau, David C Viano, Minoo Shah, et al.
Psychedelic Medicine (New Rochelle, N.Y.)
|
March 6, 2025
Past, Present, and Future of Psychedelics: A <i>Psychedelic Medicine</i> Roundtable Discussion
Peter S Hendricks, Charles D Nichols, Kathryn A Cunningham, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 17, 2008
Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium
Aura Perez, Anna M van Heeckeren, David Nichols, et al.
British Journal of Sports Medicine
|
December 4, 2018
Core temperature up to 41.5ºC during the UCI Road Cycling World Championships in the heat
Sebastien Racinais, Sebastien Moussay, David Nichols, et al.
Brain Research
|
February 13, 2007
Developmental expression of Kcnq4 in vestibular neurons and neurosensory epithelia
Sonia M S Rocha-Sanchez, Kenneth A Morris, Bechara Kachar, et al.
British Journal of Sports Medicine
|
January 30, 2020
Health status, heat preparation strategies and medical events among elite cyclists who competed in the heat at the 2016 UCI Road World Cycling Championships in Qatar
Sebastien Racinais, David Nichols, Gavin Travers, et al.
Journal of Applied Microbiology
|
April 16, 2025
Rhizosphere bacteria degrade a key root exudate metabolite critical for pathogen germination and root infection
Eda Marie Barsalote-Wei, David Nichols, Robert Steven Tegg, et al.
International Journal of Sports Physiology and Performance
|
June 29, 2017
Is There an Optimal Ischemic-Preconditioning Dose to Improve Cycling Performance?
Scott Cocking, Mathew G Wilson, David Nichols, et al.
Journal of Clinical & Translational Endocrinology
|
April 18, 2025
Cholesterol and triglyceride concentrations following 12-18 months of clinically prescribed elexacaftor-tezacaftor-ivacaftor-PROMISE sub-study
Rosara Bass, Michael Stalvey, George Solomon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 1, 2015
Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis
Amit Gaggar, Junliang Chen, James F Chmiel, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Accident; Analysis and Prevention
|
December 14, 2002
Field relevance of a suite of rollover tests to real-world crashes and injuries
Chantal S Parenteau, David C Viano, Minoo Shah, et al.
Psychedelic Medicine (New Rochelle, N.Y.)
|
March 6, 2025
Past, Present, and Future of Psychedelics: A <i>Psychedelic Medicine</i> Roundtable Discussion
Peter S Hendricks, Charles D Nichols, Kathryn A Cunningham, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 17, 2008
Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium
Aura Perez, Anna M van Heeckeren, David Nichols, et al.
British Journal of Sports Medicine
|
December 4, 2018
Core temperature up to 41.5ºC during the UCI Road Cycling World Championships in the heat
Sebastien Racinais, Sebastien Moussay, David Nichols, et al.
Brain Research
|
February 13, 2007
Developmental expression of Kcnq4 in vestibular neurons and neurosensory epithelia
Sonia M S Rocha-Sanchez, Kenneth A Morris, Bechara Kachar, et al.
British Journal of Sports Medicine
|
January 30, 2020
Health status, heat preparation strategies and medical events among elite cyclists who competed in the heat at the 2016 UCI Road World Cycling Championships in Qatar
Sebastien Racinais, David Nichols, Gavin Travers, et al.
Journal of Applied Microbiology
|
April 16, 2025
Rhizosphere bacteria degrade a key root exudate metabolite critical for pathogen germination and root infection
Eda Marie Barsalote-Wei, David Nichols, Robert Steven Tegg, et al.
International Journal of Sports Physiology and Performance
|
June 29, 2017
Is There an Optimal Ischemic-Preconditioning Dose to Improve Cycling Performance?
Scott Cocking, Mathew G Wilson, David Nichols, et al.
Journal of Clinical & Translational Endocrinology
|
April 18, 2025
Cholesterol and triglyceride concentrations following 12-18 months of clinically prescribed elexacaftor-tezacaftor-ivacaftor-PROMISE sub-study
Rosara Bass, Michael Stalvey, George Solomon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 1, 2015
Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis
Amit Gaggar, Junliang Chen, James F Chmiel, et al.
Page
of 8